Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 754 of 6351
-
Engineered immune cells take on tough gut cancers in new trial
Disease control Recruiting nowThe goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least 1 standard treatment regimen in the metastatic or locally advanced setting.
Phase 1/2 • Sponsor: Chimeric Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can smartphone sensing boost depression care for new mothers in nepal?
Symptom relief CompletedIn certain low- and middle- income country settings, there is a disproportionate level of untreated postpartum depression that presents both acute and long-term risks to a mother's well-being. Although there is increasing willingness among health systems to involve non-specialist…
Sponsor: George Washington University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy aims to control blood cancer without a cure
Disease control Recruiting nowEvaluate the safety, tolerability and pharmacokinetics of ICP-248 in Combination with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2/3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Light therapy takes aim at tough pancreatic tumors
Disease control Recruiting nowThis is a prospective, multicenter, non-randomized, open label light dose escalation phase I trial to evaluate the safety and preliminary efficacy of Padeliporfin vascular targeted photodynamic therapy (VTP) applied via endovascular fiber placement within a dilatation catheter, t…
Phase 1 • Sponsor: Impact Biotech Ltd • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Mistletoe therapy aims to stop osteosarcoma relapse
Disease control Recruiting nowThis will be a phase II, single arm study of osteosarcoma patients with fully resected pulmonary metastases. The MTD corresponds to the dosage recommendations of the manufacturer of Iscador® P which is licensed in Sweden, New Zealand, South Korea, Germany and Switzerland for the …
Phase 2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New heart pump could be lifeline for failing hearts
Disease control Recruiting nowThe primary objective of this study is to evaluate the safety and effectiveness of the Corheart 6 LVAS when used for the treatment of advanced left ventricular heart failure in a European population at 6 months post-implantation. The secondary objective is to assess the long-ter…
Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
HIV prevention shot under Long-Term watch in 3,500 volunteers
Prevention OngoingThe purpose of this study is long-term evaluation of long-acting injectable cabotegravir (CAB LA) for HIV pre-exposure prophylaxis (PrEP) in eligible participants who have completed DAIDS (Division of AIDS) sponsored studies HPTN 083 and HPTN 084 and associated sub-studies. Parti…
Phase 3 • Sponsor: ViiV Healthcare • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
New hope for kids with rare bone disease: experimental drug enters final testing
Disease control OngoingThe primary purpose of this study is to evaluate the efficacy of ALXN1850 versus placebo on radiographic outcomes in pediatric participants with HPP who have not previously been treated with asfotase alfa.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can a retinal photo reveal hidden heart risk?
Knowledge-focused Recruiting nowThis ambidirectional observational cohort study builds upon and expands an existing coronary artery disease (CAD) cohort based on retinal fundus imaging (ChiCTR2200066429). A comprehensive baseline database will be established, including demographic characteristics, laboratory te…
Sponsor: Beijing Hospital • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Could a new pill ease bipolar depression in young people?
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I or bipolar II disorder as confirmed by Kiddie Schedule for Affective Disorders an…
Phase 3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a simple pill help sepsis patients leave the ICU sooner?
Disease control Recruiting nowThis study is being done to determine if early administration of Midodrine can improve outcomes by maintaining a higher mean blood pressure off of intravenous medications. Researchers want to see if Midodrine can help people with sepsis need fewer vasopressors, which could mean s…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for aggressive uterine cancer: vaccine and drug combo trial launches
Disease control Recruiting nowBackground: Endometrial cancer (EC) of the uterus is becoming more common in the US. Sometimes EC often has increased levels of a protein called HER2. Cancers with HER2 tend to be more aggressive and have poorer outcomes. Objective: To test 2 study drugs-a vaccine that targets…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill aims to tame seizures in Drug-Resistant epilepsy
Disease control OngoingThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New RSV vaccine for infants shows promise in major trial
Vaccine Stopped earlyThis study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers which will be enrolled at approximately 6 months of age (Cohort 1) and approximately 12 months of age (Cohort 2). The primary objective of t…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Jun 27, 2026 09:01 UTC
-
Double CAR t attack: new trial targets leukemia that escapes first therapy
Disease control Recruiting nowThe primary purpose of this study is to determine safety, feasibility, and the Maximum Tolerated Dose (MTD)/Recommended Phase 2 Dose (RP2D) of CD22 Chimeric Antigen Receptor T-Cell Therapy (CART) cells when administered 28 to 42 days after an infusion of a commercial CAR called T…
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a light device at home tame implant gum disease?
Disease control Recruiting nowThis early-stage study is designed to determine the efficacy of the Lumoral method in periimplantitis. Improved supragingival plaque control can help to also sustain subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on …
Sponsor: Koite Health Oy • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could pelvic floor training straighten scoliosis curves?
Disease control OngoingThe goal of this clinical trial is to evaluate the effects of scoliosis-specific three-dimensional exercises combined with pelvic floor muscle training on scoliosis severity and spinopelvic parameters in adolescents with idiopathic scoliosis. The main questions it aims to answer …
Sponsor: Gazi University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Heart-Guided exercise may keep aging bodies stronger
Prevention CompletedThis study was conducted in collaboration with a community-based retirement facility to evaluate the clinical effectiveness of a smart, technology-assisted circuit exercise intervention for community-dwelling older adults. Traditional exercise prescriptions for older adults often…
Sponsor: Chang Gung Memorial Hospital • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Diabetes drug metformin takes on deadly brain cancer in new trial
Disease control Recruiting nowTailored approaches targeting crucial oncogenes and pathways have shown successful results in a number of cancer types and offer exciting perspective in neuro-oncology. IDH (Isocitrate dehydrogenase) wild-type (IDHwt) glioblastoma (GBM) (10%) present a unique and homogenous energ…
Phase 2 • Sponsor: Hopital Foch • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New blood pressure drug aims for Round-the-Clock control
Disease control CompletedA multicenter, randomized, double-blind, phase III study to evaluate efficacy and safety of HGP2304 in patients with essential hypertension
Phase 3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC